CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® LLC (PER®), a leading resource for continuing medical education, proudly announces it will present the International Society of Gastrointestinal Oncology® (ISGIO) 17th Annual 2020 Gastrointestinal Oncology Conference, as a two-day continuing medical education (CME)-certified virtual, interactive meeting Oct. 2-3.
This year’s conference will be chaired by renowned expert Tanios S. Bekaii-Saab, M.D., professor, Mayo Clinic College of Medicine and Science, program leader, gastrointestinal cancer, Mayo Clinic Cancer Center and medical director, cancer clinical research office, Mayo Clinic.
“The ISGIO meeting has a long, rich history of providing quality CME-certified gastrointestinal (GI) cancer education to clinicians featuring some of the best minds in the field,” said Phil Talamo, president of PER®. “We look forward to utilizing our virtual interactive platforms, as well as expert speakers and resources, to deliver a highly engaging state-of-the-art two-day conference covering the hottest topics in GI cancer for 2020.”
The 2020 Gastrointestinal Oncology Conference will provide the latest advances in the broad field of GI cancer research, as well as critical issues relevant to the care of persons with GI cancer. World-renowned thought leaders from different disciplines will educate clinicians using a combination of case-based learning, debates, panel discussions and didactic segments. Throughout the sessions, attendees will have the opportunity to interact with the faculty and ask questions via PER®’s custom interactive platform.
Accredited by the Accreditation Council for Continuing Medical Education, this live activity will provide participants with the opportunity to earn 12.0AMA PRA Category 1 Credits™.
For more information and to register, click here.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now advances patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While expanding into topics outside of oncology, PER® stands as the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.